GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

ONWARD Medical ONWD.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

1.80

+1.12%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About ONWARD Medical

Its shares trade on Euronext Brussels under the ticker ONWD.BR. It has been listed since 21 October 2021. In the fiscal year to 31 December 2025, it reported revenue of €3.8m and a net loss of €41.8m. At that date it held total assets of €84.6m and shareholders' equity of €55.3m.

Onward Medical BV operates as a medical technology company. The company is headquartered in Eindhoven, Noord-Brabant. The company went IPO on 2021-10-21. The firm is primarily engaged in developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury. The company develops two technology platforms ARC EX and ARC IM.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
21 Oct 2021
Employees
96
Website
onwd.com ↗

Leadership

Pay as last reported

  • Mr. Rob ten HoedtChairman of the Board, since 2024
  • Mr. Dave MarverChief Executive Officer, Executive Director, since 2020€3.3m
  • Mr. Curtis IanIndependent Non-Executive Vice Chairman of the Board
  • Mr. Khaled BahiChief Financial Officer
  • Mr. John MurphyChief Technology Officer
  • Mr. Andy DolanVice President Marketing
  • Mr. Vincent DelattreVice President Business Development
  • Mr. Hendrik LambertVice President Clinical & Regulatory
  • Ms. Rano BurkhanovaGlobal HR Director
  • Mr. David HarariManaging Director USA
  • Mr. Tim DenisonDirector
  • Ms. Rahma SamowDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • ARC EX platform enables functional recovery for spinal cord injury patients in the Netherlands.
  • ARC IM platform targets spinal cord injury rehabilitation with innovative medical technology.
  • Onward Medical BV employs 96 full-time staff in Eindhoven, Netherlands.

Weaknesses

  • Limited employee count of 96 may hinder rapid expansion in the Health Care sector.
  • Eindhoven headquarters restricts access to global markets without additional offices.
  • IPO on 21 October 2021 shows recent market entry with limited financial history.

Opportunities

  • Expanding spinal cord injury therapy market in the Netherlands offers growth potential.
  • ARC EX and ARC IM platforms can be commercialized in the European Health Care sector.
  • Growing demand for spinal cord injury treatments in the Health Care industry.

Threats

  • Competition from established Health Care companies in the Netherlands.
  • Regulatory challenges in the European Health Care sector for new medical devices.
  • Dependence on spinal cord injury therapy market growth in the Netherlands.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.